Merck KGaA appoints new head of pharma

pharmafile | December 17, 2010 | Appointment | Manufacturing and Production, Research and Development, Sales and Marketing |  Elmar Schnee, Merck KGaA, Merck Serono, Stefan Oschmann, appoinment, manufacturing and production, research and development, sales and marketing 

Merck KGaA has appointed Stefan Oschmann head of its pharmaceuticals division Merck Serono.

He takes office on 1 January 2011 and will also have responsibility for the company’s consumer health care operations.

Stefan worked for more than 20 years at the American company Merck & Co, most recently as president of emerging markets.

He takes over from Elmar Schnee, who joined the company in 2003 – initially heading up its French Merck Santé subsidiary – and is leaving for personal reasons.

The company has also appointed Kai Beckmann to its executive board with responsibility for the newly created executive board position of human resources.